These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 9723311
1. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. Gridelli B, Colledan M, Lucianetti A, Ulla L, Riva S, Segalin A, Fassati LR, Torre G. Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311 [No Abstract] [Full Text] [Related]
2. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J. Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224 [No Abstract] [Full Text] [Related]
3. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression. Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR. Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308 [No Abstract] [Full Text] [Related]
5. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients. Ogino S, Hashikura Y, Katsuyama Y, Ikegami T, Nakazawa Y, Urata K, Terada M, Miyagawa S, Kawasaki S. Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357 [Abstract] [Full Text] [Related]
6. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C. Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472 [No Abstract] [Full Text] [Related]
11. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group. Peeters P, Kazek M, Abella I, Noble I. Transplant Proc; 1998 Aug; 30(5):1838-42. PubMed ID: 9723301 [No Abstract] [Full Text] [Related]
12. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO. Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. Yasuhara M, Hashida T, Toraguchi M, Hashimoto Y, Kimura M, Inui K, Hori R, Inomata Y, Tanaka K, Yamaoka Y. Transplant Proc; 1995 Feb; 27(1):1108-10. PubMed ID: 7533356 [No Abstract] [Full Text] [Related]
14. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient. Falkenstein K, Dunn S. Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354 [No Abstract] [Full Text] [Related]
16. Experience with neoral cyclosporine through the oral route in liver transplantation. Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C. Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580 [No Abstract] [Full Text] [Related]